Shares of NuVasive Rise Above Previous 52-Week High
NuVasive (NASDAQ:NUVA) traded at a new 52-week high today of $66.28. So far today approximately 244,000 shares have been exchanged, as compared to an average 30-day volume of 754,000 shares.
NuVasive (NASDAQ:NUVA) is currently priced 10.6% above its average consensus analyst price target of $58.47. NuVasive shares have support at the 200-day moving average (MA) of $49.69 and additional support at the 50-day MA of $48.04.
NuVasive, Inc. designs, develops, and markets products for the surgical treatment of spine disorders. The Company's products include Maximum Access Surgery (MAS) and Fusion products.
In the past 52 weeks, shares of NuVasive have traded between a low of $36.81 and a high of $66.28 and are now at $65.43, which is 78% above that low price. The 200-day and 50-day moving averages have moved 0.12% higher and 2.23% higher over the past week, respectively.
SmarTrend recommended that subscribers consider buying shares of NuVasive on March 4th, 2016 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $43.48. Since that recommendation, shares of NuVasive have risen 50.6%. We continue to monitor NUVA for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.
Keywords: 52 week high/lows nuvasive